Kanabo Group (KNB) Share Price, News & Analysis

Company Overview

Kanabo is creating a new standard in the medical cannabis industry by improving the well-being of millions around the world. Its focus is on the distribution of Cannabis-derived products for medical patients, and non-THC products for CBD consumers. Kanabo have conducted extensive R&D in order to develop high-quality Cannabis extract formulas, innovative medical-grade vaporisers, and various non-smoking consumption solutions – making use easy and accessible for anyone in need of treatment. Clinical and validation activities, including safety and efficiency tests, are conducted in Israel – an established leader in the Cannabis industry. The company is selling initial products in Europe already, and is ready to scale up to meet market demands and projected sales and revenues.

Key Stats

• Today's Range: 0.70 to 0.84
• 50-Day Range: 0.74 to 1
• 52-Week Range: 0.70 to 2.10
• Volume: 782,352 shs
• Average Volume: 320,776 shs
• Market Capitalization: £4.68 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

KNB Stock Analysis - Frequently Asked Questions

How have KNB shares performed this year?

Kanabo Group's stock was trading at GBX 0.90 at the beginning of 2025. Since then, KNB shares have decreased by 17.8% and is now trading at GBX 0.74.
View the best growth stocks for 2025 here.

How were Kanabo Group's earnings last quarter?

Kanabo Group Plc (LON:KNB) issued its quarterly earnings data on Tuesday, October, 1st. The company reported ($0.28) EPS for the quarter. Kanabo Group had a negative trailing twelve-month return on equity of 121.77% and a negative net margin of 717.63%.

How do I buy shares of Kanabo Group?

Shares of KNB stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What other stocks do shareholders of Kanabo Group own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Kanabo Group investors own include BP (BP), Entain (ENT), Lloyds Banking Group (LLOY), Legal & General Group (LGEN), Meta Platforms (META), Piedmont Lithium (PLL) and Alliance Pharma (APH).

Company Calendar

• Last Earnings: 10/01/2024
• Today: 2/22/2025

Industry, Sector and Symbol

• Stock Exchange: LON
• Sector: Medical
• Industry: Medical Care Facilities
• Sub-Industry: N/A
• Current Symbol: LON:KNB
• CUSIP: N/A
• CIK: N/A
• Web: www.kanabogroup.com
• Phone: N/A
• Fax: N/A
• Employees: 20
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): GBX (1.29)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: £-8,181,001.68
• Net Margins: -717.63%
• Pretax Margin: N/A
• Return on Equity: -121.77%
• Return on Assets: -20.89%

Debt

• Debt-to-Equity Ratio: 3.48
• Current Ratio: 2.78
• Quick Ratio: 24.36

Sales & Book Value

• Annual Sales: £1.14 million
• Price / Sales: 4.11
• Cash Flow: GBX 0.41 per share
• Price / Cash Flow: 1.82
• Book Value: GBX 0.93 per share
• Price / Book: 0.79

Miscellaneous

• Outstanding Shares: 632,428,000
• Free Float: N/A
• Market Cap: £4.68 million
• Optionable: Not Optionable
• Beta: 3.04